Company: PFSA
Filing Date: 2025-05-13
Form Type: S-4/A
Source: 0001213900-25-042224
Chunk: 324

Company: Profusa, Inc.
Filing Date: 2025-05-13
Form: S-4/A
Chunk 324
---
 be exhaustive, but summarizes the material factors considered by the Profusa board of directors in its consideration of the Merger Agreement and the transactions contemplated. The Profusa board of directors concluded that the benefits, advantages and opportunities of a potential transaction outweighed the uncertainties and risks described above. After considering these and other factors, the Profusa board of directors unanimously approved the Merger Agreement, the merger and the other transactions contemplated by the Merger Agreement. 163 Certain Persons in the Business Combination and Conflicts of Interest When you consider the recommendation of NorthView’s Board in favor of approval of the Business Combination Proposal, you should keep in mind that the Sponsor and certain of NorthView’s directors, officers and initial stockholders have interests in the Business Combination that are different from, or in addition to, your interests as a stockholder. These interests include, among other things: •the beneficial ownership of the Sponsor and certain of NorthView’s directors of an aggregate of 88.7% of outstanding NorthView Common Stock, which shares would become worthless if NorthView does not complete a business combination within the applicable time period, as the Sponsor and NorthView’s officers directors have waived any right to redemption with respect to these shares. Such shares have an aggregate market value of approximately $[] based on the closing price of NorthView Common Stock of $[•] on [•], 2025 the Record Date for the special meeting of stockholders; •the beneficial ownership of the Sponsor of 5,162,500 Private Placement Warrants, for which it paid $5,162,500 and which will expire and be worthless if NorthView does not complete a business combination within the applicable time period; •NorthView’s officers and directors have an aggregate of $560,833 invested in the Sponsor, which will be lost in the event that the Business Combination is not approved and concluded; •Certain of NorthView’s officers and directors have invested an aggregate of $115,000 into Profusa’s Bridge Notes, which will be converted into shares of Profusa and exchanged for shares of New Profusa Common Stock in connection with the Merger; •NorthView’s directors will not receive reimbursement for all out -of-pocketexpenses incurred by them on NorthView’s behalf incident to identifying, investigating and consummating a business combination, unless a business combination is consummated (as of the date hereof, $22,650 have been incurred); •Up to an aggregate amount of $2,500,000 of any amounts outstanding under any working capital loans made